OOIR: Observatory of International Research

Papers

(The H4-Index of mAbs is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
In silico prediction of post-translational modifications in therapeutic antibodies	288
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries	210
Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms	112
Correction	89
Development of a novel, high-throughput imaged capillary isoelectric focusing-Western method to characterize charge heterogeneity of monoclonal antibody heavy and light chains	82
Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae	81
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex	68
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability	62
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma	59
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties	58
An antibody developability triaging pipeline exploiting protein language models	55
Correction	52
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis	47
Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies	41
A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies	41
Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn	37
Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning	37
Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity	37
Impact of IgG subclass on monoclonal antibody developability	36
Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets	35
Antibodies to watch in 2024	33
Predicting antibody binders and generating synthetic antibodies using deep learning	33
Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies	33
The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains	31
Mitochondrial membrane potential-enriched CHO host: a novel and powerful tool for improving biomanufacturing capability	30

The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics	29
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs	28
In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy	28